Financial Survey: OptimizeRx (NASDAQ:OPRX) versus Eqonex (NASDAQ:EQOS)

Eqonex (NASDAQ:EQOSGet Free Report) and OptimizeRx (NASDAQ:OPRXGet Free Report) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

Earnings & Valuation

This table compares Eqonex and OptimizeRx’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Eqonex $5.29 million 0.00 -$75.00 million N/A N/A
OptimizeRx $83.20 million 1.82 -$17.57 million ($1.02) -8.15

OptimizeRx has higher revenue and earnings than Eqonex.

Analyst Ratings

This is a summary of recent ratings for Eqonex and OptimizeRx, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Eqonex 0 0 0 0 N/A
OptimizeRx 0 1 4 0 2.80

OptimizeRx has a consensus price target of $14.50, indicating a potential upside of 74.49%.

Volatility & Risk

Eqonex has a beta of 1.83, suggesting that its stock price is 83% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.

Institutional & Insider Ownership

76.5% of OptimizeRx shares are owned by institutional investors. 4.4% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Eqonex and OptimizeRx’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Eqonex N/A N/A N/A
OptimizeRx -21.53% -5.97% -4.42%

Summary

OptimizeRx beats Eqonex on 5 of the 9 factors compared between the two stocks.

About Eqonex

(Get Free Report)

Eqonex Limited operates as a digital assets financial services company. It operates through three divisions: Custody, Asset Management, and Brokerage. The company provides Digivault, a custody solution; Bletchley Park, a digital asset investment solution for institutional and professional investors; and EQONEX Investment products that issues securitized products. It also operates an over-the-counter brokerage, and borrowing and lending services, as well as structured products. The company was formerly known as Diginex Limited and changed its name to Eqonex Limited in October 2021. Eqonex Limited is headquartered in Singapore.

About OptimizeRx

(Get Free Report)

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Receive News & Ratings for Eqonex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eqonex and related companies with MarketBeat.com's FREE daily email newsletter.